Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Teucrium Soybean Fund — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.96 (market cap $1.74B), while Teucrium Soybean Fund trades at $27.55 (market cap $43.52M). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 40× Teucrium Soybean Fund's market cap, and Teucrium Soybean Fund is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Teucrium Soybean Fund for 23 Days on average.
| NUVB | SOYB | |
|---|---|---|
Market Cap | $1.74B | $43.52M |
Volume | 9,289,619 | 32,585 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $9.54 | $28.14 |
52-Week Low | $3.41 | $21.55 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $1.33B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
